Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Latest filing published 03 Sept 2021 for Osmotica Pharmaceuticals plc, €16k.
Insider track record
Disclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Fred G. Weiss: trading record in brief
This profile gathers the share dealings of Fred G. Weiss across 3 companies, led by Watson Pharmaceuticals Inc, Allergan plc and RVL Pharmaceuticals plc. The record holds 40 filings, for trades running from 4 May 2007 to 27 August 2021.
No open-market purchase appears, only 10 sales worth €3.4M. Other entries cover 27 share grants and 2 option exercises.
Most recently, on 3 September 2021, the filings show a share grant worth €16k in RVL Pharmaceuticals plc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Fred G. Weiss
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
5,506 shares@ US$3.3125.6% of flowOrdinary SharesSEC:0001104659-21-112911:0
61,188 shares0Ordinary SharesSEC:0001104659-21-089771:0
18,584 shares@ US$2.8974.4% of flowOrdinary SharesSEC:0001104659-21-084094:0
3 of 3 declarations
